Redox-mediated dissolution of paramagnetic nanolids to achieve a smart theranostic system.
Manganese oxide (Mn3O4) nanoparticles have recently emerged as a promising T1 contrast agent. In this study, for the first time, we demonstrated an interaction of Mn3O4 with a biological system, and found redox sensitive behavior of these paramagnetic nanoparticles in intracellular reducing environment. Inspired by these findings, we for the first time used this interaction for some therapeutic advantages and designed a versatile mesoporous silica based nanotheranostic system to realize redox-activated enhanced magnetic resonance imaging and responsive anticancer drug delivery. Contrary to previous reports, we firstly prepared high quality amine terminated hydrophilic Mn3O4 nanolids, without using multistep ligand exchange strategies. The resulting water stable and small-sized Mn3O4 nanolids were subsequently used as nanolids to cap drug loaded nanochannels of a porous carrier. Exposure to highly prevalent intracellular reducing environment resulted in the steady-state dissolution of these nanolids and attained an intelligent drug release. Furthermore, the redox receptive dissolution of paramagnetic Mn3O4 nanolids into Mn(2+) in turn increases the T1 signal to twofold, providing an added opportunity to even track the feedback of therapy. This study, in addition to simultaneously realizing drug delivery and imaging, also provides a new insight into the fate and interaction of manganese oxide nanoparticles with components of biological systems.
State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, 130012, China. zhugs@jlu.edu.cn.
Aifei
A
Wang
Mingyi
M
Guo
Nan
N
Wang
Jianyun
J
Zhao
Wenxiu
W
Qi
Faheem
F
Muhammad
Liang
L
Chen
Yingjie
Y
Guo
Nam-Trung
NT
Nguyen
Guangshan
G
Zhu
D045744:Cell Line, Tumor; D003692:Delayed-Action Preparations / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D017895:Manganese Compounds / Q000737:chemistry / Q000494:pharmacology; D008422:Materials Testing; D053758:Nanoparticles / Q000737:chemistry*; D010087:Oxides / Q000737:chemistry / Q000494:pharmacology
D003692:Delayed-Action Preparations; D017895:Manganese Compounds; D010087:Oxides; C027424:manganese oxide